- Home
- PANL vs NYXH Comparison
PANL vs NYXH Comparison
Compare PANL & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- NYXH
- Stock Information
- Founded
- PANL 1996
- NYXH 2009
- Country
- PANL United States
- NYXH Belgium
- Employees
- PANL N/A
- NYXH N/A
- Industry
- PANL Marine Transportation
- NYXH Medical/Dental Instruments
- Sector
- PANL Consumer Discretionary
- NYXH Health Care
- Exchange
- PANL Nasdaq
- NYXH Nasdaq
- Market Cap
- PANL 357.3M
- NYXH 394.1M
- IPO Year
- PANL N/A
- NYXH 2021
- Fundamental
- Price
- PANL $4.81
- NYXH $6.82
- Analyst Decision
- PANL Strong Buy
- NYXH Strong Buy
- Analyst Count
- PANL 1
- NYXH 4
- Target Price
- PANL N/A
- NYXH $14.75
- AVG Volume (30 Days)
- PANL 275.4K
- NYXH 81.7K
- Earning Date
- PANL 03-13-2025
- NYXH 03-13-2025
- Dividend Yield
- PANL 8.25%
- NYXH N/A
- EPS Growth
- PANL 8.62
- NYXH N/A
- EPS
- PANL 0.63
- NYXH N/A
- Revenue
- PANL $536,536,246.00
- NYXH $4,680,609.00
- Revenue This Year
- PANL $13.67
- NYXH $504.18
- Revenue Next Year
- PANL $6.04
- NYXH $149.52
- P/E Ratio
- PANL $7.56
- NYXH N/A
- Revenue Growth
- PANL 7.46
- NYXH 3.98
- 52 Week Low
- PANL $4.67
- NYXH $6.76
- 52 Week High
- PANL $8.32
- NYXH $13.50
- Technical
- Relative Strength Index (RSI)
- PANL 36.49
- NYXH 23.12
- Support Level
- PANL $4.67
- NYXH $10.26
- Resistance Level
- PANL $5.06
- NYXH $11.87
- Average True Range (ATR)
- PANL 0.18
- NYXH 0.77
- MACD
- PANL -0.05
- NYXH -0.45
- Stochastic Oscillator
- PANL 7.84
- NYXH 1.19
Stock Price Comparison Chart: PANL vs NYXH
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.